History of Breast Implants
Posted: Sunday, March 01, 2009
by Dr Mai Brooks
maibrooksmd
Co-author is Dr. James Watson.
The first documented attempt to augment (enlarge) the breast happened 119 years ago. For the first 68 years, breast augmentation was attempted by direct injection with materials, including paraffin, fat, and free silicone. These attempts led to disastrous consequences including infection, hard breast lumps, deformity, fat absorption, fat necrosis, and chronic inflammatory reactions. Removal was difficult, sometimes leading to measures as drastic as mastectomy. After the invention of the mammogram, these injections were found to create artifacts that made cancer screening more difficult. For these reasons, direct injections of the breast were abandoned by most plastic surgeons in the US. Free silicone injections into the breast for augmentation still continued in many other countries into the latter part of the 20 th century, however.
Today most patients in the US are choosing silicone gel implants for both cosmetic and reconstructive breast surgery again, but the capsular contracture (breast hardening) rates are no better today than they were in the 1960s when these implants were first developed. In retrospect, capsular contracture was the major complication with the first attempt at augmentation in 1890 and is still the major complication with breast augmentation in 2009. Despite this well known fact, the majority of the attention given to implants over the 119-year period has focused on implant rupture and unsubstantiated claims that implants cause systemic human disease.
Current silicone gel filled implants in the US are what many call "4 th generation" implants, which have much stricter manufacturing standards and testing standards. "5 th generation" implants have already been in use in Europe for ten years and in Canada for five years, but are still not approved by the FDA. These "5 th generation" implants are cohesive gel implants commonly referred to as "gummy bear" implants. The advantages of these implants include less rippling and the lack of gel extrusion/leak if the silicone elastomer shell breaks. There are also hopes that these implants would have a lower capsular contracture rate, but preliminary evidence suggests that contracture is still a major problem as with all previous generations of implants.
We must learn from the history of silicone gel implants and not repeat history again. Good scientific research must precede commerce and marketing. The cost of bringing a new implant to market has exponentially increased as a result of FDA requirements and legal risk. Now most new implants are first being tested in Europe or South America and often are approved decades there before approval in the US. Many clinical trials are being done worldwide on existing implants and on new implants before US market approval is obtained. Long term studies still need to be done on implant rupture rates. Innovations need to be made to reduce the most common complication, capsular contracture, which still occurs today after 119 years of history.
Dr. Mai Brooks is a surgical oncologist/general surgeon, with expertise in early detection and prevention of cancer. More at www.drbrooksmd.com, thecancerexperience.wordpress.com and progressreportoncancer.wordpress.com.
This Article has been viewed 343 times. (Not updated in real-time.)
No comments yet.We want your comments! If you can read this, you don't have javascript enabled, so you can't use this comment system. Please enable javascript.